Funds · PHAT

Who owns PHAT?

Institutional ownership of Phathom Pharmaceuticals Inc. from Form 13F, Q2 2026

162 institutional managers reported holding Phathom Pharmaceuticals Inc. (PHAT) in Form 13F filings for Q2 2026, with 72,073,934 shares worth $782M. The largest reported holder was Frazier Life Sciences Management, L.P. Managers that filed both quarters added a net 2,937,842 shares (+4.3%). 21 opened new positions and 32 sold out.

Funds holding
162
Value held
$782M
New / sold out
21 / 32
Net shares, same filers
+4.3%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of PHAT

FundValueShare of 13F holdingsSharesMove
Frazier Life Sciences Management, L.P.$135M17.3%12,466,489Unchanged
Medicxi Ventures Management (Jersey) Ltd$81.0M10.4%7,464,572Unchanged
BlackRock, Inc.$49.1M6.3%4,525,129Added
Invesco Ltd.$43.7M5.6%4,029,731Trimmed
Carlyle Group Inc.$37.9M4.9%3,496,808Unchanged
Millennium Management LLC$36.6M4.7%3,375,834Trimmed
Vanguard Capital Management LLC$28.8M3.7%2,656,944Added
GW&K Investment Management, LLC$23.5M3.0%2,166,838Added
Franklin Resources Inc$21.4M2.7%1,970,828Added
NEA Management Company, LLC$21.3M2.7%1,960,169Unchanged
683 Capital Management, LLC$20.1M2.6%1,850,000Unchanged
Goldman Sachs Group Inc$19.3M2.5%1,778,032Added
State Street Corp$17.2M2.2%1,586,323Added
Catalys Pacific, LLC$16.2M2.1%1,493,854Unchanged
Nomura Asset Management International Inc.$15.9M2.0%1,462,738Added
Geode Capital Management, LLC$14.3M1.8%1,315,687Trimmed
Wasatch Advisors LP$14.2M1.8%1,307,247Trimmed
Ensign Peak Advisors, Inc$11.4M1.5%1,051,913Trimmed
Propel Bio Management, LLC$11.4M1.5%1,050,358Added
Point72 Asset Management, L.P.$11.1M1.4%1,022,193New
Vanguard Portfolio Management LLC$8.6M1.1%796,631Added
SummitTX Capital, L.P.$8.6M1.1%789,550Trimmed
HSBC Holdings PLC$7.7M1.0%709,695New
Marshall Wace, LLP$7.2M0.9%666,090Trimmed
EcoR1 Capital, LLC$6.8M0.9%625,000Unchanged

Share of 13F holdings is each fund's shares as a share of the 72,073,934 PHAT shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $89.2M and sold $57.6M; 59 added and 50 trimmed.

Schedule 13D and 13G filings on PHAT

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about PHAT ownership

Who owns PHAT stock?
162 institutional investment managers reported PHAT positions in their Form 13F filings for Q2 2026, holding 72,073,934 shares worth $782M in total. Frazier Life Sciences Management, L.P. reported the largest position.
Are funds buying or selling PHAT?
In Q2 2026, 21 managers opened new PHAT positions, 59 added, 50 trimmed and 32 sold out. Managers that filed in both quarters added a net 2,937,842 shares.
How current is this PHAT institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PHAT by CUSIP. Options are left out. PHAT news and filings · PHAT insider trades · Top funds